Inventor · disambiguated record
Alain Prochiantz
Also filed as: PROCHIANTZ ALAIN
14 granted patents·7 pending applications·178 citations·filing 1994–2021
90Inventor score
Files withCENTRE NAT RECH SCIENT13PROCHIANTZ ALAIN4ECOLE NORMALE SUPERIEURE1GSF FORSCHUNGSZENTRUM UMWELT1JOLIOT ALAIN1
Top patents by PatentIndex Score
21 records- 0184US5888762ANeurotropic growth factors comprising a homeobox peptideCENTRE NAT RECH SCIENT·Filed 1994·Granted Mar 30, 1999·76 cites·20 claims
- 0280US6080724APeptides which can be used as vectors for the intracellular addressing of active moleculesCENTRE NAT RECH SCIENT·Filed 1996·Granted Jun 27, 2000·77 cites·25 claims
- 0379US10100307B2Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseasesCENTRE NAT RECH SCIENT·Filed 2015·Granted Oct 16, 2018·8 cites·9 claims
- 0473US9950033B2Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neuronsPROCHIANTZ ALAIN·Filed 2012·Granted Apr 24, 2018·1 cites·9 claims
- 0568US8575105B2Use of the engrailed homeodomain protein as anxiolyticPROCHIANTZ ALAIN·Filed 2007·Granted Nov 5, 2013·3 cites·4 claims
- 0667US7115380B2Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)CENTRE NAT RECH SCIENT·Filed 2005·Granted Oct 3, 2006·1 cites·2 claims
- 0766US9868783B2Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexusCENTRE NAT RECH SCIENT·Filed 2014·Granted Jan 16, 2018·1 cites·9 claims
- 0864US8242088B2Carrier vectors through an epithelium with tight junctionsJOLIOT ALAIN·Filed 2001·Granted Aug 14, 2012·6 cites·7 claims
- 0963US10342851B2Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neuronsCENTRE NAT RECH SCIENT·Filed 2018·Granted Jul 9, 2019·0 cites·9 claims
- 1062US2021379144A1Homeoproteins for use in the treatment of neurodegenerative disordersCENTRE NAT RECH SCIENT·Filed 2021·Application pending·0 cites
- 1156US6905832B1Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP)CENTRE NAT RECH SCIENT·Filed 2000·Granted Jun 14, 2005·1 cites·6 claims
- 1254US10842852B2Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptideCENTRE NAT RECH SCIENT·Filed 2016·Granted Nov 24, 2020·0 cites·5 claims
- 1350US10722554B2Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoproteinPROCHIANTZ ALAIN·Filed 2009·Granted Jul 28, 2020·0 cites·8 claims
- 1449US2009131320A1Peptides modulating the activity of the engrailed transcription factorCENTRE NAT RECH SCIENT·Filed 2008·Application pending·0 cites
- 1549US2018142012A1Inhibition of the synthesis of beta-app or of the activity of the a-beta peptide in the choroid plexusCENTRE NAT RECH SCIENT·Filed 2017·Application pending·0 cites
- 1645US2019247461A1Homeoproteins for use in the treatment of neurodegenerative disordersCENTRE NAT RECH SCIENT·Filed 2016·Application pending·0 cites
- 1742US11357816B2Ligand controling interaction between gags with their effector molecules and use thereofCENTRE NAT RECH SCIENT·Filed 2019·Granted Jun 14, 2022·0 cites·20 claims
- 1841US2007054401A1Composition for intracellular transport of biological particles or macromoleculesECOLE NORMALE SUPERIEURE·Filed 2003·Application pending·0 cites
- 1940US2007155668A1Peptides modulating the activity of the engrailed transcription factorUNIV PARIS 13 NORD·Filed 2004·Application pending·0 cites
- 2038US6656735B1Method for identification of target genes of transcription factorsGSF FORSCHUNGSZENTRUM UMWELT·Filed 1998·Granted Dec 2, 2003·4 cites·15 claims
- 2135US2012015884A1Polypeptides for Specific Targeting to Otx2 Target CellsPROCHIANTZ ALAIN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alain Prochiantz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →